AGILENT TECHNOLOGIES INC's ticker is A and the CUSIP is 00846U101. A total of 988 filers reported holding AGILENT TECHNOLOGIES INC in Q2 2024. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About AGILENT TECHNOLOGIES INC
Agilent Technologies Inc. is a leading global provider of life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent's mission is to improve the quality of life by enabling people to live healthier and longer.
Agilent's products and services are used in a wide range of applications, including pharmaceuticals, biotechnology, environmental testing, food testing, and forensics. The company's portfolio includes instruments, software, consumables, and services that enable customers to analyze, identify, and quantify substances with accuracy and precision.
Agilent has a strong commitment to innovation and invests heavily in research and development. The company has a team of over 1,200 scientists and engineers who work on developing new technologies and improving existing ones. Agilent's focus on innovation has resulted in numerous breakthroughs, including the development of the first commercial gas chromatograph and the first commercial atomic absorption spectrophotometer.
Agilent is also committed to sustainability and corporate responsibility. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. Agilent is also committed to ethical business practices and has a strong code of conduct that guides its employees' behavior.
In conclusion, Agilent Technologies Inc. is a leading provider of life sciences, diagnostics, and applied chemical markets. The company's commitment to innovation, sustainability, and corporate responsibility has made it a trusted partner for customers around the world. With a strong focus on research and development, Agilent is well-positioned to continue driving innovation and improving the quality of life for people everywhere.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $30,000 | +200.0% | 193 | -19.6% | 0.01% | -12.5% |
| Q1 2015 | $10,000 | 0.0% | 240 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $10,000 | -28.6% | 240 | 0.0% | 0.01% | -30.0% |
| Q3 2014 | $14,000 | 0.0% | 240 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $14,000 | +7.7% | 240 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $13,000 | -7.1% | 240 | 0.0% | 0.01% | -16.7% |
| Q4 2013 | $14,000 | – | 240 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOPLITE CAPITAL MANAGEMENT, L.P. | 1,614,133 | $95,734,000 | 5.55% |
| Bristol Gate Capital Partners Inc. | 504,544 | $29,925,000 | 4.58% |
| CANTILLON CAPITAL MANAGEMENT LLC | 5,013,259 | $297,337,000 | 3.71% |
| HAHN CAPITAL MANAGEMENT LLC | 593,133 | $35,178,718,000 | 3.65% |
| Impax Asset Management LTD | 1,833,751 | $108,760,000 | 3.65% |
| Robeco Schweiz AG | 529,844 | $31,155,000 | 2.61% |
| Orbimed Advisors | 3,814,100 | $226,214,000 | 2.37% |
| CYPRESS CAPITAL MANAGEMENT LLC | 142,308 | $8,440,000 | 2.02% |
| Nitorum Capital, L.P. | 158,981 | $9,429,000 | 1.88% |
| Lombard Odier Asset Management (Switzerland) SA | 266,779 | $15,823,000 | 1.82% |